Overweight or obesity
Clinical trials for Overweight or obesity explained in plain language.
Never miss a new study
Get alerted when new Overweight or obesity trials appear
Sign up with your email to follow new studies for Overweight or obesity, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can an experimental injection help people with obesity shed pounds?
Disease control Not yet recruitingResearchers are testing an experimental injection called SYH2069 in adults who are overweight or obese but do not have diabetes. The study compares the drug against a placebo over 28 weeks to see if it leads to meaningful weight loss. Participants receive either SYH2069 or a plac…
Matched conditions: OVERWEIGHT OR OBESITY
Phase 2 • Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could a new injection help tackle obesity? a safety trial begins
Disease control Not yet recruitingThis early-stage trial is testing an investigational injection called SYH2092 in healthy adults who are overweight or have obesity. The main goal is to see if the drug is safe and tolerable, while also measuring how it moves through the body. Participants receive either the injec…
Matched conditions: OVERWEIGHT OR OBESITY
Phase 1 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Weekly shot could help shed pounds in obesity trial
Disease control Not yet recruitingThis phase 2 study tests HRS-4729, a once-weekly injection, for weight loss in adults with obesity who do not have diabetes. About 252 participants will receive either the drug or a placebo. The main goal is to see how much body weight changes after 32 weeks compared to a placebo…
Matched conditions: OVERWEIGHT OR OBESITY
Phase 2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New obesity drug SYH2082 enters first human safety trial
Disease control Not yet recruitingThis Phase 1 study tests a single dose of SYH2082 injection in 44 healthy adults who are overweight or have obesity. The main goal is to check safety and side effects, not weight loss. Participants will receive either the drug or a placebo, and researchers will monitor how the dr…
Matched conditions: OVERWEIGHT OR OBESITY
Phase 1 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New Weight-Loss shot enters first human safety trial
Disease control Not yet recruitingThis early-stage study tests an experimental drug called CMS-D008 in 110 healthy and overweight or obese adults. The main goal is to check safety and how the body processes the drug, not weight loss. Participants will receive either the drug or a placebo as injections, and resear…
Matched conditions: OVERWEIGHT OR OBESITY
Phase 1 • Sponsor: Shenzhen Kangzhe Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New pill could help shed pounds without surgery
Disease control Not yet recruitingThis study tests an experimental oral drug called MDR-001 to help adults with overweight or obesity lose weight over 52 weeks. About 738 participants will receive either the drug or a placebo, along with lifestyle advice. The main goal is to see if the drug leads to meaningful we…
Matched conditions: OVERWEIGHT OR OBESITY
Phase 3 • Sponsor: MindRank AI Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC